Chemically induced knockdown of SMARCA2/4 to treat AML

DISEASE CATEGORY: Cancer

INDICATION: Acute myelogenous leukemia (AML)

Boehringer Ingelheim GmbH and University of Dundee showed that proteolysis-targeting chimeric molecules

Read the full 192 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE